nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Tonsillitis—Citalopram—alcohol dependence	0.0199	0.0199	CcSEcCtD
Tobramycin—Sputum increased—Citalopram—alcohol dependence	0.0193	0.0193	CcSEcCtD
Tobramycin—Increased bronchial secretion—Citalopram—alcohol dependence	0.0181	0.0181	CcSEcCtD
Tobramycin—Endophthalmitis—Acamprosate—alcohol dependence	0.0176	0.0176	CcSEcCtD
Tobramycin—Eye pain—Disulfiram—alcohol dependence	0.0137	0.0137	CcSEcCtD
Tobramycin—Platelet count decreased—Naltrexone—alcohol dependence	0.0133	0.0133	CcSEcCtD
Tobramycin—Musculoskeletal chest pain—Citalopram—alcohol dependence	0.013	0.013	CcSEcCtD
Tobramycin—Pharyngolaryngeal pain—Naltrexone—alcohol dependence	0.0117	0.0117	CcSEcCtD
Tobramycin—Laryngeal pain—Naltrexone—alcohol dependence	0.0116	0.0116	CcSEcCtD
Tobramycin—Eye pruritus—Citalopram—alcohol dependence	0.0112	0.0112	CcSEcCtD
Tobramycin—Laryngitis—Naltrexone—alcohol dependence	0.011	0.011	CcSEcCtD
Tobramycin—Eyelid oedema—Citalopram—alcohol dependence	0.00996	0.00996	CcSEcCtD
Tobramycin—Throat irritation—Citalopram—alcohol dependence	0.00996	0.00996	CcSEcCtD
Tobramycin—Blood glucose increased—Citalopram—alcohol dependence	0.00982	0.00982	CcSEcCtD
Tobramycin—Injection site pain—Naltrexone—alcohol dependence	0.00971	0.00971	CcSEcCtD
Tobramycin—Dysphonia—Naltrexone—alcohol dependence	0.00964	0.00964	CcSEcCtD
Tobramycin—Neuropathy peripheral—Disulfiram—alcohol dependence	0.00933	0.00933	CcSEcCtD
Tobramycin—Delirium—Naltrexone—alcohol dependence	0.00922	0.00922	CcSEcCtD
Tobramycin—Cough increased—Acamprosate—alcohol dependence	0.00916	0.00916	CcSEcCtD
Tobramycin—Chest discomfort—Naltrexone—alcohol dependence	0.00896	0.00896	CcSEcCtD
Tobramycin—Creatinine increased—Acamprosate—alcohol dependence	0.00881	0.00881	CcSEcCtD
Tobramycin—Oropharyngeal pain—Naltrexone—alcohol dependence	0.00872	0.00872	CcSEcCtD
Tobramycin—Platelet count decreased—Citalopram—alcohol dependence	0.00845	0.00845	CcSEcCtD
Tobramycin—Phosphatase alkaline increased—Acamprosate—alcohol dependence	0.00838	0.00838	CcSEcCtD
Tobramycin—Keratitis—Citalopram—alcohol dependence	0.00775	0.00775	CcSEcCtD
Tobramycin—Rash maculo-papular—Acamprosate—alcohol dependence	0.00762	0.00762	CcSEcCtD
Tobramycin—Pharyngolaryngeal pain—Citalopram—alcohol dependence	0.00744	0.00744	CcSEcCtD
Tobramycin—Laryngeal pain—Citalopram—alcohol dependence	0.00737	0.00737	CcSEcCtD
Tobramycin—Hyperventilation—Citalopram—alcohol dependence	0.0073	0.0073	CcSEcCtD
Tobramycin—Thrombophlebitis—Acamprosate—alcohol dependence	0.00703	0.00703	CcSEcCtD
Tobramycin—Blood alkaline phosphatase increased—Acamprosate—alcohol dependence	0.007	0.007	CcSEcCtD
Tobramycin—Laryngitis—Citalopram—alcohol dependence	0.00697	0.00697	CcSEcCtD
Tobramycin—Deafness—Acamprosate—alcohol dependence	0.0068	0.0068	CcSEcCtD
Tobramycin—Renal failure acute—Acamprosate—alcohol dependence	0.00659	0.00659	CcSEcCtD
Tobramycin—Swelling—Naltrexone—alcohol dependence	0.00653	0.00653	CcSEcCtD
Tobramycin—Dermatitis exfoliative—Acamprosate—alcohol dependence	0.00645	0.00645	CcSEcCtD
Tobramycin—Disorientation—Naltrexone—alcohol dependence	0.00644	0.00644	CcSEcCtD
Tobramycin—Nasal congestion—Naltrexone—alcohol dependence	0.00632	0.00632	CcSEcCtD
Tobramycin—Dysphonia—Citalopram—alcohol dependence	0.00611	0.00611	CcSEcCtD
Tobramycin—Eye irritation—Citalopram—alcohol dependence	0.00588	0.00588	CcSEcCtD
Tobramycin—Lethargy—Naltrexone—alcohol dependence	0.00587	0.00587	CcSEcCtD
Tobramycin—Delirium—Citalopram—alcohol dependence	0.00584	0.00584	CcSEcCtD
Tobramycin—Blood creatinine increased—Acamprosate—alcohol dependence	0.0057	0.0057	CcSEcCtD
Tobramycin—Chest discomfort—Citalopram—alcohol dependence	0.00568	0.00568	CcSEcCtD
Tobramycin—Dry skin—Acamprosate—alcohol dependence	0.00558	0.00558	CcSEcCtD
Tobramycin—Bone disorder—Citalopram—alcohol dependence	0.00556	0.00556	CcSEcCtD
Tobramycin—Hypocalcaemia—Citalopram—alcohol dependence	0.00549	0.00549	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00548	0.00548	CcSEcCtD
Tobramycin—Oliguria—Citalopram—alcohol dependence	0.00545	0.00545	CcSEcCtD
Tobramycin—Paraesthesia—Disulfiram—alcohol dependence	0.00545	0.00545	CcSEcCtD
Tobramycin—Drug interaction—Citalopram—alcohol dependence	0.00542	0.00542	CcSEcCtD
Tobramycin—Dehydration—Naltrexone—alcohol dependence	0.00535	0.00535	CcSEcCtD
Tobramycin—Leukocytosis—Citalopram—alcohol dependence	0.00535	0.00535	CcSEcCtD
Tobramycin—Blood bilirubin increased—Citalopram—alcohol dependence	0.00531	0.00531	CcSEcCtD
Tobramycin—Asthma—Acamprosate—alcohol dependence	0.00526	0.00526	CcSEcCtD
Tobramycin—Eosinophilia—Acamprosate—alcohol dependence	0.00521	0.00521	CcSEcCtD
Tobramycin—Pain—Disulfiram—alcohol dependence	0.00519	0.00519	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00518	0.00518	CcSEcCtD
Tobramycin—Bronchitis—Acamprosate—alcohol dependence	0.00506	0.00506	CcSEcCtD
Tobramycin—Phosphatase alkaline increased—Citalopram—alcohol dependence	0.00502	0.00502	CcSEcCtD
Tobramycin—Wheezing—Citalopram—alcohol dependence	0.00488	0.00488	CcSEcCtD
Tobramycin—Bronchitis—Naltrexone—alcohol dependence	0.00478	0.00478	CcSEcCtD
Tobramycin—Weight decreased—Acamprosate—alcohol dependence	0.00476	0.00476	CcSEcCtD
Tobramycin—Dry eye—Citalopram—alcohol dependence	0.00464	0.00464	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00462	0.00462	CcSEcCtD
Tobramycin—Stomatitis—Acamprosate—alcohol dependence	0.00457	0.00457	CcSEcCtD
Tobramycin—Rash maculo-papular—Citalopram—alcohol dependence	0.00457	0.00457	CcSEcCtD
Tobramycin—Weight decreased—Naltrexone—alcohol dependence	0.0045	0.0045	CcSEcCtD
Tobramycin—Infestation NOS—Naltrexone—alcohol dependence	0.00444	0.00444	CcSEcCtD
Tobramycin—Infestation—Naltrexone—alcohol dependence	0.00444	0.00444	CcSEcCtD
Tobramycin—Epistaxis—Acamprosate—alcohol dependence	0.00442	0.00442	CcSEcCtD
Tobramycin—Asthenia—Disulfiram—alcohol dependence	0.00436	0.00436	CcSEcCtD
Tobramycin—Ear pain—Citalopram—alcohol dependence	0.00428	0.00428	CcSEcCtD
Tobramycin—Rhinitis—Acamprosate—alcohol dependence	0.00422	0.00422	CcSEcCtD
Tobramycin—Blood alkaline phosphatase increased—Citalopram—alcohol dependence	0.00419	0.00419	CcSEcCtD
Tobramycin—Epistaxis—Naltrexone—alcohol dependence	0.00418	0.00418	CcSEcCtD
Tobramycin—Pharyngitis—Acamprosate—alcohol dependence	0.00418	0.00418	CcSEcCtD
Tobramycin—Sinusitis—Naltrexone—alcohol dependence	0.00416	0.00416	CcSEcCtD
Tobramycin—Disorientation—Citalopram—alcohol dependence	0.00408	0.00408	CcSEcCtD
Tobramycin—Deafness—Citalopram—alcohol dependence	0.00408	0.00408	CcSEcCtD
Tobramycin—Visual impairment—Acamprosate—alcohol dependence	0.00406	0.00406	CcSEcCtD
Tobramycin—Eye pain—Citalopram—alcohol dependence	0.00404	0.00404	CcSEcCtD
Tobramycin—Dizziness—Disulfiram—alcohol dependence	0.00401	0.00401	CcSEcCtD
Tobramycin—Nasal congestion—Citalopram—alcohol dependence	0.004	0.004	CcSEcCtD
Tobramycin—Pharyngitis—Naltrexone—alcohol dependence	0.00395	0.00395	CcSEcCtD
Tobramycin—Renal failure acute—Citalopram—alcohol dependence	0.00395	0.00395	CcSEcCtD
Tobramycin—Tinnitus—Acamprosate—alcohol dependence	0.00392	0.00392	CcSEcCtD
Tobramycin—Connective tissue disorder—Naltrexone—alcohol dependence	0.00391	0.00391	CcSEcCtD
Tobramycin—Rash—Disulfiram—alcohol dependence	0.00383	0.00383	CcSEcCtD
Tobramycin—Headache—Disulfiram—alcohol dependence	0.0038	0.0038	CcSEcCtD
Tobramycin—Immune system disorder—Acamprosate—alcohol dependence	0.0038	0.0038	CcSEcCtD
Tobramycin—Lethargy—Citalopram—alcohol dependence	0.00372	0.00372	CcSEcCtD
Tobramycin—Eye disorder—Naltrexone—alcohol dependence	0.00372	0.00372	CcSEcCtD
Tobramycin—Tinnitus—Naltrexone—alcohol dependence	0.00371	0.00371	CcSEcCtD
Tobramycin—Angiopathy—Naltrexone—alcohol dependence	0.00361	0.00361	CcSEcCtD
Tobramycin—Immune system disorder—Naltrexone—alcohol dependence	0.0036	0.0036	CcSEcCtD
Tobramycin—Mediastinal disorder—Naltrexone—alcohol dependence	0.00359	0.00359	CcSEcCtD
Tobramycin—Dysgeusia—Acamprosate—alcohol dependence	0.00359	0.00359	CcSEcCtD
Tobramycin—Back pain—Acamprosate—alcohol dependence	0.00354	0.00354	CcSEcCtD
Tobramycin—Ill-defined disorder—Acamprosate—alcohol dependence	0.0034	0.0034	CcSEcCtD
Tobramycin—Dysgeusia—Naltrexone—alcohol dependence	0.00339	0.00339	CcSEcCtD
Tobramycin—Dehydration—Citalopram—alcohol dependence	0.00339	0.00339	CcSEcCtD
Tobramycin—Anaemia—Acamprosate—alcohol dependence	0.00339	0.00339	CcSEcCtD
Tobramycin—Back pain—Naltrexone—alcohol dependence	0.00335	0.00335	CcSEcCtD
Tobramycin—Angioedema—Acamprosate—alcohol dependence	0.00335	0.00335	CcSEcCtD
Tobramycin—Dry skin—Citalopram—alcohol dependence	0.00334	0.00334	CcSEcCtD
Tobramycin—Hypokalaemia—Citalopram—alcohol dependence	0.00332	0.00332	CcSEcCtD
Tobramycin—Malaise—Acamprosate—alcohol dependence	0.0033	0.0033	CcSEcCtD
Tobramycin—Vertigo—Acamprosate—alcohol dependence	0.00329	0.00329	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00328	0.00328	CcSEcCtD
Tobramycin—Leukopenia—Acamprosate—alcohol dependence	0.00328	0.00328	CcSEcCtD
Tobramycin—Vision blurred—Naltrexone—alcohol dependence	0.00327	0.00327	CcSEcCtD
Tobramycin—Muscular weakness—Citalopram—alcohol dependence	0.00322	0.00322	CcSEcCtD
Tobramycin—Ill-defined disorder—Naltrexone—alcohol dependence	0.00322	0.00322	CcSEcCtD
Tobramycin—Cough—Acamprosate—alcohol dependence	0.0032	0.0032	CcSEcCtD
Tobramycin—Angioedema—Naltrexone—alcohol dependence	0.00317	0.00317	CcSEcCtD
Tobramycin—Asthma—Citalopram—alcohol dependence	0.00315	0.00315	CcSEcCtD
Tobramycin—Malaise—Naltrexone—alcohol dependence	0.00313	0.00313	CcSEcCtD
Tobramycin—Eosinophilia—Citalopram—alcohol dependence	0.00312	0.00312	CcSEcCtD
Tobramycin—Myalgia—Acamprosate—alcohol dependence	0.00312	0.00312	CcSEcCtD
Tobramycin—Chest pain—Acamprosate—alcohol dependence	0.00312	0.00312	CcSEcCtD
Tobramycin—Bronchospasm—Citalopram—alcohol dependence	0.0031	0.0031	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.0031	0.0031	CcSEcCtD
Tobramycin—Discomfort—Acamprosate—alcohol dependence	0.00308	0.00308	CcSEcCtD
Tobramycin—Bronchitis—Citalopram—alcohol dependence	0.00303	0.00303	CcSEcCtD
Tobramycin—Cough—Naltrexone—alcohol dependence	0.00303	0.00303	CcSEcCtD
Tobramycin—Confusional state—Acamprosate—alcohol dependence	0.00302	0.00302	CcSEcCtD
Tobramycin—Anaphylactic shock—Acamprosate—alcohol dependence	0.00299	0.00299	CcSEcCtD
Tobramycin—Chest pain—Naltrexone—alcohol dependence	0.00295	0.00295	CcSEcCtD
Tobramycin—Myalgia—Naltrexone—alcohol dependence	0.00295	0.00295	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00293	0.00293	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00293	0.00293	CcSEcCtD
Tobramycin—Thrombocytopenia—Acamprosate—alcohol dependence	0.00293	0.00293	CcSEcCtD
Tobramycin—Discomfort—Naltrexone—alcohol dependence	0.00292	0.00292	CcSEcCtD
Tobramycin—Skin disorder—Acamprosate—alcohol dependence	0.0029	0.0029	CcSEcCtD
Tobramycin—Confusional state—Naltrexone—alcohol dependence	0.00285	0.00285	CcSEcCtD
Tobramycin—Weight decreased—Citalopram—alcohol dependence	0.00285	0.00285	CcSEcCtD
Tobramycin—Anorexia—Acamprosate—alcohol dependence	0.00285	0.00285	CcSEcCtD
Tobramycin—Anaphylactic shock—Naltrexone—alcohol dependence	0.00283	0.00283	CcSEcCtD
Tobramycin—Infestation NOS—Citalopram—alcohol dependence	0.00281	0.00281	CcSEcCtD
Tobramycin—Infestation—Citalopram—alcohol dependence	0.00281	0.00281	CcSEcCtD
Tobramycin—Nervous system disorder—Naltrexone—alcohol dependence	0.00277	0.00277	CcSEcCtD
Tobramycin—Neuropathy peripheral—Citalopram—alcohol dependence	0.00276	0.00276	CcSEcCtD
Tobramycin—Skin disorder—Naltrexone—alcohol dependence	0.00275	0.00275	CcSEcCtD
Tobramycin—Stomatitis—Citalopram—alcohol dependence	0.00274	0.00274	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00272	0.00272	CcSEcCtD
Tobramycin—Anorexia—Naltrexone—alcohol dependence	0.0027	0.0027	CcSEcCtD
Tobramycin—Paraesthesia—Acamprosate—alcohol dependence	0.00269	0.00269	CcSEcCtD
Tobramycin—Dyspnoea—Acamprosate—alcohol dependence	0.00267	0.00267	CcSEcCtD
Tobramycin—Epistaxis—Citalopram—alcohol dependence	0.00265	0.00265	CcSEcCtD
Tobramycin—Sinusitis—Citalopram—alcohol dependence	0.00264	0.00264	CcSEcCtD
Tobramycin—Agranulocytosis—Citalopram—alcohol dependence	0.00262	0.00262	CcSEcCtD
Tobramycin—Decreased appetite—Acamprosate—alcohol dependence	0.0026	0.0026	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00258	0.00258	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00258	0.00258	CcSEcCtD
Tobramycin—Pain—Acamprosate—alcohol dependence	0.00256	0.00256	CcSEcCtD
Tobramycin—Paraesthesia—Naltrexone—alcohol dependence	0.00254	0.00254	CcSEcCtD
Tobramycin—Rhinitis—Citalopram—alcohol dependence	0.00253	0.00253	CcSEcCtD
Tobramycin—Dyspnoea—Naltrexone—alcohol dependence	0.00252	0.00252	CcSEcCtD
Tobramycin—Pharyngitis—Citalopram—alcohol dependence	0.0025	0.0025	CcSEcCtD
Tobramycin—Urinary tract disorder—Citalopram—alcohol dependence	0.00249	0.00249	CcSEcCtD
Tobramycin—Connective tissue disorder—Citalopram—alcohol dependence	0.00248	0.00248	CcSEcCtD
Tobramycin—Urethral disorder—Citalopram—alcohol dependence	0.00247	0.00247	CcSEcCtD
Tobramycin—Feeling abnormal—Acamprosate—alcohol dependence	0.00246	0.00246	CcSEcCtD
Tobramycin—Decreased appetite—Naltrexone—alcohol dependence	0.00246	0.00246	CcSEcCtD
Tobramycin—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00245	0.00245	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00244	0.00244	CcSEcCtD
Tobramycin—Visual impairment—Citalopram—alcohol dependence	0.00243	0.00243	CcSEcCtD
Tobramycin—Pain—Naltrexone—alcohol dependence	0.00242	0.00242	CcSEcCtD
Tobramycin—Urticaria—Acamprosate—alcohol dependence	0.00238	0.00238	CcSEcCtD
Tobramycin—Body temperature increased—Acamprosate—alcohol dependence	0.00236	0.00236	CcSEcCtD
Tobramycin—Abdominal pain—Acamprosate—alcohol dependence	0.00236	0.00236	CcSEcCtD
Tobramycin—Eye disorder—Citalopram—alcohol dependence	0.00236	0.00236	CcSEcCtD
Tobramycin—Tinnitus—Citalopram—alcohol dependence	0.00235	0.00235	CcSEcCtD
Tobramycin—Feeling abnormal—Naltrexone—alcohol dependence	0.00233	0.00233	CcSEcCtD
Tobramycin—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00231	0.00231	CcSEcCtD
Tobramycin—Angiopathy—Citalopram—alcohol dependence	0.00229	0.00229	CcSEcCtD
Tobramycin—Immune system disorder—Citalopram—alcohol dependence	0.00228	0.00228	CcSEcCtD
Tobramycin—Mediastinal disorder—Citalopram—alcohol dependence	0.00227	0.00227	CcSEcCtD
Tobramycin—Urticaria—Naltrexone—alcohol dependence	0.00225	0.00225	CcSEcCtD
Tobramycin—Body temperature increased—Naltrexone—alcohol dependence	0.00224	0.00224	CcSEcCtD
Tobramycin—Abdominal pain—Naltrexone—alcohol dependence	0.00224	0.00224	CcSEcCtD
Tobramycin—Hypersensitivity—Acamprosate—alcohol dependence	0.0022	0.0022	CcSEcCtD
Tobramycin—Erythema—Citalopram—alcohol dependence	0.0022	0.0022	CcSEcCtD
Tobramycin—Dysgeusia—Citalopram—alcohol dependence	0.00215	0.00215	CcSEcCtD
Tobramycin—Asthenia—Acamprosate—alcohol dependence	0.00215	0.00215	CcSEcCtD
Tobramycin—Back pain—Citalopram—alcohol dependence	0.00212	0.00212	CcSEcCtD
Tobramycin—Pruritus—Acamprosate—alcohol dependence	0.00212	0.00212	CcSEcCtD
Tobramycin—Hypersensitivity—Naltrexone—alcohol dependence	0.00208	0.00208	CcSEcCtD
Tobramycin—Vision blurred—Citalopram—alcohol dependence	0.00207	0.00207	CcSEcCtD
Tobramycin—Diarrhoea—Acamprosate—alcohol dependence	0.00205	0.00205	CcSEcCtD
Tobramycin—Ill-defined disorder—Citalopram—alcohol dependence	0.00204	0.00204	CcSEcCtD
Tobramycin—Anaemia—Citalopram—alcohol dependence	0.00203	0.00203	CcSEcCtD
Tobramycin—Asthenia—Naltrexone—alcohol dependence	0.00203	0.00203	CcSEcCtD
Tobramycin—Angioedema—Citalopram—alcohol dependence	0.00201	0.00201	CcSEcCtD
Tobramycin—Pruritus—Naltrexone—alcohol dependence	0.002	0.002	CcSEcCtD
Tobramycin—Malaise—Citalopram—alcohol dependence	0.00198	0.00198	CcSEcCtD
Tobramycin—Dizziness—Acamprosate—alcohol dependence	0.00198	0.00198	CcSEcCtD
Tobramycin—Vertigo—Citalopram—alcohol dependence	0.00197	0.00197	CcSEcCtD
Tobramycin—Leukopenia—Citalopram—alcohol dependence	0.00197	0.00197	CcSEcCtD
Tobramycin—Diarrhoea—Naltrexone—alcohol dependence	0.00194	0.00194	CcSEcCtD
Tobramycin—Cough—Citalopram—alcohol dependence	0.00192	0.00192	CcSEcCtD
Tobramycin—Vomiting—Acamprosate—alcohol dependence	0.0019	0.0019	CcSEcCtD
Tobramycin—Rash—Acamprosate—alcohol dependence	0.00189	0.00189	CcSEcCtD
Tobramycin—Dermatitis—Acamprosate—alcohol dependence	0.00188	0.00188	CcSEcCtD
Tobramycin—Headache—Acamprosate—alcohol dependence	0.00187	0.00187	CcSEcCtD
Tobramycin—Dizziness—Naltrexone—alcohol dependence	0.00187	0.00187	CcSEcCtD
Tobramycin—Myalgia—Citalopram—alcohol dependence	0.00187	0.00187	CcSEcCtD
Tobramycin—Chest pain—Citalopram—alcohol dependence	0.00187	0.00187	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00186	0.00186	CcSEcCtD
Tobramycin—Discomfort—Citalopram—alcohol dependence	0.00185	0.00185	CcSEcCtD
Tobramycin—Confusional state—Citalopram—alcohol dependence	0.00181	0.00181	CcSEcCtD
Tobramycin—Vomiting—Naltrexone—alcohol dependence	0.0018	0.0018	CcSEcCtD
Tobramycin—Anaphylactic shock—Citalopram—alcohol dependence	0.00179	0.00179	CcSEcCtD
Tobramycin—Rash—Naltrexone—alcohol dependence	0.00178	0.00178	CcSEcCtD
Tobramycin—Dermatitis—Naltrexone—alcohol dependence	0.00178	0.00178	CcSEcCtD
Tobramycin—Nausea—Acamprosate—alcohol dependence	0.00178	0.00178	CcSEcCtD
Tobramycin—Headache—Naltrexone—alcohol dependence	0.00177	0.00177	CcSEcCtD
Tobramycin—Nervous system disorder—Citalopram—alcohol dependence	0.00176	0.00176	CcSEcCtD
Tobramycin—Thrombocytopenia—Citalopram—alcohol dependence	0.00176	0.00176	CcSEcCtD
Tobramycin—Skin disorder—Citalopram—alcohol dependence	0.00174	0.00174	CcSEcCtD
Tobramycin—Anorexia—Citalopram—alcohol dependence	0.00171	0.00171	CcSEcCtD
Tobramycin—Nausea—Naltrexone—alcohol dependence	0.00168	0.00168	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00163	0.00163	CcSEcCtD
Tobramycin—Paraesthesia—Citalopram—alcohol dependence	0.00161	0.00161	CcSEcCtD
Tobramycin—Dyspnoea—Citalopram—alcohol dependence	0.0016	0.0016	CcSEcCtD
Tobramycin—Decreased appetite—Citalopram—alcohol dependence	0.00156	0.00156	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00155	0.00155	CcSEcCtD
Tobramycin—Pain—Citalopram—alcohol dependence	0.00153	0.00153	CcSEcCtD
Tobramycin—Feeling abnormal—Citalopram—alcohol dependence	0.00148	0.00148	CcSEcCtD
Tobramycin—Gastrointestinal pain—Citalopram—alcohol dependence	0.00147	0.00147	CcSEcCtD
Tobramycin—Urticaria—Citalopram—alcohol dependence	0.00142	0.00142	CcSEcCtD
Tobramycin—Abdominal pain—Citalopram—alcohol dependence	0.00142	0.00142	CcSEcCtD
Tobramycin—Body temperature increased—Citalopram—alcohol dependence	0.00142	0.00142	CcSEcCtD
Tobramycin—Hypersensitivity—Citalopram—alcohol dependence	0.00132	0.00132	CcSEcCtD
Tobramycin—Asthenia—Citalopram—alcohol dependence	0.00129	0.00129	CcSEcCtD
Tobramycin—Pruritus—Citalopram—alcohol dependence	0.00127	0.00127	CcSEcCtD
Tobramycin—Diarrhoea—Citalopram—alcohol dependence	0.00123	0.00123	CcSEcCtD
Tobramycin—Dizziness—Citalopram—alcohol dependence	0.00119	0.00119	CcSEcCtD
Tobramycin—Vomiting—Citalopram—alcohol dependence	0.00114	0.00114	CcSEcCtD
Tobramycin—Rash—Citalopram—alcohol dependence	0.00113	0.00113	CcSEcCtD
Tobramycin—Dermatitis—Citalopram—alcohol dependence	0.00113	0.00113	CcSEcCtD
Tobramycin—Headache—Citalopram—alcohol dependence	0.00112	0.00112	CcSEcCtD
Tobramycin—Nausea—Citalopram—alcohol dependence	0.00106	0.00106	CcSEcCtD
